News
For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...
Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...
Billionaire Kerr Neilson has bought over $290,715 worth of shares in CVS Health Corporation (NYSE:CVS), representing 0.02% of ...
7h
Zacks.com on MSNCVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
The most important philosophy we have of AI is that AI will never make decisions. Period. So AI would help us collect the ...
CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...
Explore more
2d
Zacks Investment Research on MSNCVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should KnowCVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...
U.S. insurers are requesting the biggest premium increases for Obamacare plans since 2018, according to an analysis by health ...
The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, ...
This was the stock's second consecutive day of losses.
RICHMOND — Starting next year, Aetna clients in Virginia and other states will no longer be able to purchase individual or ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results